Cleared Traditional

K190102 - DyeVert™ Plus Contrast Reduction System, DyeTect™ Contrast Monitoring System, DyeVert™ Plus EZ Contrast Reduction System (FDA 510(k) Clearance)

Oct 2019
Decision
268d
Days
Class 2
Risk

K190102 is an FDA 510(k) clearance for the DyeVert™ Plus Contrast Reduction System, DyeTect™ Contrast Monitoring System, DyeVert™ Plus EZ Contrast Reduction System. This device is classified as a Injector And Syringe, Angiographic (Class II - Special Controls, product code DXT).

Submitted by Osprey Medical, Inc. (Minnetonka, US). The FDA issued a Cleared decision on October 17, 2019, 268 days after receiving the submission on January 22, 2019.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 870.1650.

Submission Details

510(k) Number K190102 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 2019
Decision Date October 17, 2019
Days to Decision 268 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code DXT - Injector And Syringe, Angiographic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1650